GD2-CAR T cell therapy for H3K27M-mutated diffuse midline gliomasRobbie G. Majzner, Michelle Monje|Nature|2022Cited by 769
Co-opting signalling molecules enables logic-gated control of CAR T cellsAidan M. Tousley, Robbie G. Majzner|Nature|2023Cited by 281
Transition to a mesenchymal state in neuroblastoma confers resistance to anti-GD2 antibody via reduced expression of ST8SIA1Nathaniel W. Mabe, Robbie G. Majzner|Nature Cancer|2022Cited by 106